Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Ovarian Epithelial 3Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sezary Syndrome 2Sarcoma 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Mycosis Fungoides 2Multiple Myeloma 2Mesothelioma, Malignant 2Melanoma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Hairy Cell 2Kidney Neoplasms 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Congenital Abnormalities 2Carcinoma, Renal Cell 2Burkitt Lymphoma 2

Interventions

Ifosfamide 3Etoposide 3Thiotepa 2Stem Cell Transplantation 2Radiotherapy 2Melphalan 2Irinotecan 2Filgrastim 2thymoglobulin 1temsirolimus 1sargramostim 1robatumumab 1omburtamab I-131 1fludarabine phosphate 1etoposide phosphate 1Valproic Acid 1Temozolomide 1Tacrolimus 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Neoadjuvant Therapy 1Mycophenolic Acid 1Microarray Analysis 1Mesna 1Immunohistochemistry 1Immunoenzyme Techniques 1Granulocyte Colony-Stimulating Factor 1FANG vaccine 1Doxorubicin 1Dexrazoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neuroectodermal Tumors, Primitive, Peripheral × Immunoenzyme Techniques × Clear all
NCT00544778 2014-08-28

Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma

City of Hope Medical Center

Phase 2 Terminated
7 enrolled 2 charts
Sarcoma

Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡